The Best Laid Plans...

October 28, 2025
Schuyler Ballroom
Congress created the 340B Program in 1992 to help safety-net hospitals and clinics care for vulnerable and uninsured patients. Under 340B, manufacturers provide significantly discounted medicines to certain clinics and hospitals. The original intent was for these entities to either pass the discounts on to patients or reinvest their 340B profits to support more charity care. However, even the best laid plans can sometimes go awry and today, the 340B program has morphed into a massive profit generator for pharmacy chains, hospitals and middlemen like pharmacy benefit managers (PBMs), failing to deliver discounted medicines to the patients who need them most.
Moderator
Ashley John
Ashley John, Director, Issue Advocacy - Novartis
Speakers
Kimberly Beer
Kimberly Beer, Senior Vice President, Policy and External Affairs - National Health Council
Brian Connell
Brian Connell, Vice President, Federal Affairs - Blood Cancer United (formerly the Leukemia & Lymphoma Society)
Patrick Wildman
Patrick Wildman, Senior Vice President, Advocacy & Government Relations - Lupus Foundation of America